Nephrology Is Finally Getting US Food and Drug Administration Approvals for Rare Glomerular Disease Medications

With: Brian Mandell, MD, PhD, MACR, MACP and Jonathan Taliercio, DO, FASN

Brian Mandell, MD, PhD, MACR, MACP and Jonathan Taliercio, DO, FASN from Cleveland Clinic review early session: Accelerated Approval: How Nephrology Is Finally Getting US Food and Drug Administration Approvals for Rare Glomerular Disease Medications and What It Means, presented at Kidney Week 2023.

← Back to Kidney Week 2023